Effects of a therapeutic weight loss diet on weight loss and metabolic health in overweight and obese dogs.

Obesity has become a major health issue in dogs. Obesity in dogs increases the risk of many chronic diseases and chronic low-grade inflammation. The objective of this study was to determine the effect of a therapeutic weight loss (TWL) diet on weight loss and metabolic health in overweight and obese dogs. Thirty overweight and obese dogs were randomized into two groups with 15 dogs per group based on key baseline (BSL) parameters and allotted to either a control or TWL diet for 6 mo. At the start of the study, the control group had six females and nine males with mean age of 9.12 ±â€…0.48 (mean ±â€…SEM) yr; there were seven females and eight males with mean age of 9.73 ±â€…0.63 yr in the TWL group. The control group and the TWL group had comparable body weight (34.78 ±â€…0.76 and 34.63 ±â€…0.86 kg, respectively), % body fat (BF; 39.77 ±â€…1.18 and 39.89 ±â€…0.93, respectively), and body condition score (BCS; 7.80 ±â€…0.14 and 7.67 ±â€…0.16 on a 9-point BCS scale, respectively). The control (CTRL) diet was formulated based on the macronutrient ratio of a commercial metabolic diet, and the TWL diet was enriched with dietary protein, fish oil, and soy germ meal. Both diets were fortified with essential nutrients to account for caloric restriction during weight loss. Dogs were fed with 25% less than BSL maintenance energy requirement (MER) for the first 4 mo and if they did not reach a BCS of 5, they were fed 40% less than BSL MER for the last 2 mo. Body composition was determined by dual-energy x-ray absorptiometry. Postprandial glucose profiles were determined by continuous glucose monitoring devices. Serum samples were collected for analyses of blood parameters, hormones, and cytokines. All data were analyzed using SAS 9.3, with significance being P < 0.05. At the end of the study, the control group and the TWL group had comparable weight loss (-5.77 ±â€…0.31 and -6.14 ±â€…0.32 kg, respectively; P = 0.4080). But the TWL group lost significantly (P = 0.034) more BF (-13.27 ±â€…1.28%) than the control group (-9.90 ±â€…1.23%). In addition, the TWL diet completely prevented loss of lean body mass (LBM) in dogs compared with BSL. Dogs fed with the TWL diet had significantly lower fasting serum cholesterol, triglycerides, insulin, leptin, mean postprandial interstitial glucose, and pro-inflammatory cytokines compared with dogs fed with the CTRL diet. In summary, the TWL diet prevented loss of LBM, promoted weight loss and metabolic health, and reduced pro-inflammatory cytokines and chemokines in overweight and obese dogs during weight loss.

Obesity has become a major health issue in dogs and increases the risk of many chronic diseases and chronic low-grade inflammation. The objective of this study was to determine the effect of a therapeutic weight loss (TWL) diet on weight loss and metabolic health in overweight and obese dogs. Thirty overweight and obese dogs were randomized into two groups with 15 dogs per group and assigned to either a control (CTRL) diet or TWL diet for a 6 mo weight loss study. Changes in body composition were determined every 2 mo. Blood samples were collected to measure changes in lipid profiles, hormones, cytokines, and chemokines. Postprandial glucose profiles were determined by a continuous glucose monitoring system. The results of the study showed that the TWL diet completely prevented loss of lean body mass (LBM) in dogs compared with baseline. Dogs fed with the TWL diet had significantly lower fasting serum cholesterol, triglycerides, insulin, leptin, mean postprandial glucose, and pro-inflammatory cytokines compared with dogs fed with the CTRL diet. In summary, the TWL diet prevented loss of LBM, promoted weight loss and metabolic health, and reduced pro-inflammatory cytokines in overweight and obese dogs during weight loss.

Effects of dietary macronutrient composition and feeding frequency on fasting and postprandial hormone response in domestic cats.

The objective was to evaluate the effects of dietary macronutrients and feeding frequency on blood glucose, insulin, total ghrelin and leptin. A total of twelve adult lean neutered male cats were used in three tests, all cross-over studies composed of a 15 d adaptation and blood sampling on day 16. In trial 1, differences between two- and four-meal feeding were tested. On day 16, blood samples were collected every 2 h for 24 h. In trial 2, macronutrient boluses were tested. Instead of the control diet, the morning meal on day 16 was replaced with an isoenergetic bolus of carbohydrate (maltodextrin), protein (chicken meat), fat or water. Fasted and ten postprandial blood samples were collected. In trial 3, diets high in fat (HF), protein (HP), carbohydrate (HC) or a control diet were tested. On day 16, fasted and ten postprandial blood samples were collected. Data were analysed to identify baseline and AUC changes. Cats fed four meals daily had greater (P = 0·03) leptin incremental AUC0-24 h compared with cats fed twice daily. The carbohydrate bolus increased glucose (P < 0·001) and insulin (P < 0·001) incremental AUC0-6 h and tended to increase (P = 0·09) leptin net AUC0-6 h. Cats fed the control and HC diets had greater (P = 0·03) glucose incremental AUC compared with the HF and HP conditions. Circulating hormone data were highly variable and indicated changes due to dietary macronutrients and feeding frequency, but further study is needed to identify impacts on appetite and contributing mechanisms.

A novel resistant maltodextrin alters gastrointestinal tolerance factors, fecal characteristics, and fecal microbiota in healthy adult humans.

OBJECTIVE: Resistant maltodextrin has been shown to increase fecal bulk by resisting digestion and being partially fermented by colonic bacteria to short-chain fatty acids (SCFA). The objective of this experiment was to determine potential prebiotic effects, gastrointestinal tolerance, and fecal characteristics of free-living humans fed a novel resistant maltodextrin or a normal maltodextrin control. METHODS: Subjects (n = 38) were enrolled in a randomized, double-blind study where they were assigned to one of three daily treatments: 15 g maltodextrin; 7.5 g maltodextrin plus 7.5 g resistant maltodextrin (Fibersol-2; Matsutani Chemical Company, Hyogo, Japan); and 15 g resistant maltodextrin. The experiment lasted 7 wk and consisted of a 2 wk baseline period, a 3 wk treatment period, and a 2 wk washout period. During wk 3 to 5 (treatment period), subjects consumed their assigned treatments. RESULTS: Resistant maltodextrin supplementation tended to increase (p = 0.12) fecal Bifidobacterium populations during the treatment period, altered (p < 0.05) bacterial populations from baseline to treatment, and resulted in very minor effects in gastrointestinal tolerance. There was a shift (p < 0.05) in molar proportions of SCFA towards butyrate, the preferred energy substrate of colonocytes. CONCLUSION: Resistant maltodextrin supplementation was well tolerated, resulted in favorable fermentation characteristics in the large bowel, and also resulted in a change in bacterial populations.

In vitro fermentation characteristics of selected glucose-based polymers by canine and human fecal bacteria.

This research evaluated fermentation characteristics (short-chain fatty acid [SCFA] production, pH, and gas production) resulting from fermentation of glucose-based carbohydrates using canine (n = 3) and human (n = 3) fecal inoculum. Substrates included lyophilized canine ileal digesta containing maltodextrin, gamma-cyclodextrin, high molecular weight (MW) pullulan (MW 100000), or low MW pullulan (MW 6300) obtained from an in vivo experiment. Fermentation for 6 and 10 h with human fecal microflora resulted in higher gas and SCFA production than did canine fecal microflora. High MW pullulan fermentation resulted in the highest (p < 0.05) gas production and lowest (p < 0.05) pH for both dogs and humans. Total SCFA production was highest (p < 0.05) for low MW pullulan fermented by canine microflora, and for gamma-cyclodextrin, high MW pullulan, and low MW pullulan fermented by human microflora. Differences were noted in fermentation characteristics of substrates present in ileal digesta.

Effects of lactoferrin supplementation on ileal and total tract nutrient digestibility, gastrointestinal microbial populations, and immune characteristics of ileal cannulated, healthy, adult dogs.

Orally supplemented lactoferrin derived from bovine milk is purported to have beneficial effects on gut health of animals. Bovine lactoferrin (0, 60, or 120 mg/d) was fed to ileal cannulated, adult dogs in a replicated 3 x 3 Latin square design with 14 d periods. Control dogs tended (p = 0.06) to have higher fecal DM concentrations compared with dogs supplemented with 120 mg/d lactoferrin (34.5 vs. 32.9%). Fecal scores ranged from 3.0 - 3.3, suggesting that feces of all dogs was near the desired consistency, with dogs supplemented with 120 mg/d lactoferrin tending (p = 0.08) to have higher fecal scores. Ileal azoreductase activity tended (p < 0.10) to be higher in dogs supplemented with 60 or 120 mg/d lactoferrin (609 vs. 592 nmol/h per g ileal DM, respectively) as compared with unsupplemented dogs (272 nmol/h per g ileal DM). The following bacterial groups were measured: bifidobacteria, Campylobacter spp., Clostridium spp., eubacteria, Escherichia coli, Lactobacillus spp., Staphylococcus spp., and Streptococcus spp. Fecal streptococci concentrations were lower (p < 0.05) for dogs receiving 60 mg/d lactoferrin (8.60 log10 cfu/g fecal DM) as compared with unsupplemented dogs (9.19 log10 cfu/g fecal DM) or dogs receiving 120mg lactoferrin/d (9.43 log10 cfu/g fecal DM). Dogs supplemented with 120mg/d lactoferrin tended (p = 0.08) to have higher fecal indole concentrations as compared to unsupplemented dogs (1.80 vs. 1.46 micromol/g fecal DM). Because most bacterial groups measured were unaffected, it appears that lactoferrin did not exhibit prebiotic activity, and based on the data collected, lactoferrin also did not appear to have major effects on indices of health in the dog.

Influence of supplemental high molecular weight pullulan or gamma-cyclodextrin on ileal and total tract nutrient digestibility, fecal characteristics, and microbial populations in the dog.

This study was conducted to determine if supplemental pullulan and gamma-cyclodextrin affect canine nutrient digestibility, microbial populations, and fecal characteristics. Ileal cannulated dogs were fed a commercial diet, and treatments were administered daily in a 5 x 5 Latin square design: (i) no supplement; (ii) 2 g pullulan; (iii) 4 g pullulan; (iv) 2 g gamma-cyclodextrin; (v) 4 g gamma-cyclodextrin. Ileal and fecal samples were collected the last 4 d of each 14-d period. Increasing pullulan tended (p < 0.10) to linearly increase ileal bifidobacteria and lactobacilli and quadratically increase fecal lactobacilli. A similar response was noted in ileal bifidobacteria and lactobacilli with gamma-cyclodextrin. Gamma-Cyclodextrin resulted in a quadratic decrease (p < 0.05) in fecal Clostridium perfringens. Increasing pullulan linearly increased (p < 0.05) fecal score, while gamma-cyclodextrin resulted in a linear decrease (p < 0.05). Pullulan and gamma-cyclodextrin supplementation may have beneficial effects on the microbial ecology of dogs.

Pullulans and gamma-cyclodextrin affect apparent digestibility and metabolism in healthy adult ileal cannulated dogs.

Pullulan and gamma-cyclodextrin are incompletely digestible, glucose-based, nonstructural carbohydrates synthesized by microorganisms. To determine their effect when incorporated into a complete liquid diet on ileal and total tract nutrient digestibility, ileal cannulated dogs (n = 8) were used in a repeated 4 x 4 Latin-square design. Twice daily, diets were offered containing 30% (DMB) maltodextrin, high-molecular-weight (MW) pullulan (MW 100,000), low-MW pullulan (MW 6300), or gamma-cyclodextrin. Fecal and ileal samples were collected for the last 4 d of each 10-d period. Dogs consuming high-MW pullulan had lower (P < 0.05) dry matter, organic matter, crude protein, fat, carbohydrate ileal and total tract digestibilities, and fecal DM, and higher (P < 0.05) fecal output and fecal scores (indicating looser stools). To evaluate glycemic and insulinemic responses to pullulans, food-deprived dogs consumed 25 g maltodextrin, high-MW pullulan, or low-MW pullulan in a repeated 3 x 3 Latin-square design. Glucose and insulin responses were determined for 180 min. Consumption of 25 g alpha-, beta-, and gamma-cyclodextrin resulted in regurgitation within 60 min. High-MW pullulan reduced (P < 0.05) blood glucose concentration at 15, 30, 45, and 60 min. Compared with maltodextrin, low-MW pullulan and gamma-cyclodextrin did not alter nutrient digestibilities or fecal characteristics to any extent, and low MW pullulan did not affect glycemic response. Although high MW pullulan decreased glycemic response, consumption of large amounts negatively affected nutrient digestibility and fecal characteristics.

Amino acid, carbohydrate, and fat composition of soybean meals prepared at 55 commercial U.S. soybean processing plants.

To quantify variation in U.S. soybean meals (SBM), samples were collected from 55 U.S. soybean (SB) processing plants located in seven of the geographic SB maturity zones at three time points. These samples were analyzed for crude and acid-hydrolyzed fat, oligosaccharide, and amino acid concentrations. Acid-hydrolyzed fat concentrations were poorly correlated (r = 0.28) to crude fat concentrations and were higher for SBM prepared in the southern zones (V-VII) as compared with the northern zones (I and II). Raffinose and verbascose concentrations were lowest (P < 0.05) for SBM prepared in northern maturity zones, while stachyose concentrations were highest for SBM prepared in central maturity zones (III and IV). Total essential, total nonessential, and total amino acid concentrations were lowest for SBM prepared in northern zones. There was variation in oligosaccharide and amino acid concentrations over time, probably due to variation in composition of SB arriving at the plants within maturity zone.

Resistant starch as related to companion animal nutrition.

Companion animal diets may contain up to 50% starch, derived from cereal grains. The amount of resistant starch (RS) in an ingredient depends on the origin and form of the ingredient and on the processing conditions to which the ingredient has been exposed. Extrusion has proven to be a means of optimizing utilization of starch by companion animals. Although the RS fraction of starch typically decreases by extrusion, retrogradation can result in increased concentrations of this fraction. Limited research exists regarding the effects of RS in companion animal nutrition and gastrointestinal health. Existing in vitro and in vivo research indicates that certain RS sources are readily fermented in the large bowel, producing short-chain fatty acids, whereas others are less fermentable, resulting in excellent laxation properties. Feeding dogs a diet high in RS may result in an increase in fecal bulk due to an increased excretion of microbial matter in those cases where RS is highly fermentable, or to indigestibility of the RS source in other cases. RS has a role to play as a potential proxy for dietary fiber, especially for those companion animals fed diets high in protein and fat and devoid of traditional dietary fiber.

Evaluation of sodium bisulphate and phosphoric acid as urine acidifiers for cats.

Eighteen cats were used to compare the urine acidifying properties of sodium bisulphate to phosphoric acid. Acidifying agents were added at one of three concentrations (0.4, 0.6, or 0.8%, as-is basis). Cats were offered a commercial diet to determine basal urinary pH, and then again for a 1 week period between blocks 1 and 2. Cats were acclimated to the diets for 6 days, and urine samples were collected on day 7 at 0, 4, and 8 h postfeeding to obtain pre- and postprandial urinary pH. Intakes of diets containing sodium bisulphate tended (P < 0.07) to be lower than intakes of diets containing phosphoric acid. Cats consuming the 0.8% phosphoric acid diet had higher (P < 0.05) food intakes than cats consuming either the 0.4 or 0.6% phosphoric acid-containing diets. There was significant (P = 0.01) linear and quadratic response for food intake in cats consuming the sodium bisulphate-containing diet. Cats consuming the 0.4 and 0.8% phosphoric acid-containing diets tended (P = 0.07) to have higher water intakes than cats consuming the 0.6% phosphoric acid-containing diet. There were no differences (P > 0.05) in urine pH and specific gravity between cats fed the different acidifier types. Cats consuming the 0.6% phosphoric acid-containing diet tended (P = 0.07) to have a higher urine pH 8 h post-feeding than cats consuming the 0.4 and 0.8% phosphoric acid-containing diets. Urine pH was highest at 4 h post-feeding except for cats fed the 0.4% sodium bisulphate- and the 0.6% phosphoric acid-containing diets. No differences (P > 0.05) between acidifiers were found in faecal score or in faecal dry matter and organic matter concentrations. A quadratic response was detected in faecal score for cats consuming the phosphoric acid-containing diets. Cats consuming the 0.6% phosphoric acid diet tended (P = 0.06) to have a lower faecal score than cats consuming the 0.4 and 0.8% phosphoric acid diets. For faecal dry matter, a linear trend was detected in cats consuming the sodium bisulphate (P = 0.08) and phosphoric acid-containing (P = 0.04) diets. Sodium bisulphate and phosphoric acid generally behaved in a similar fashion when incorporated in dry cat diets.